IRCT20180212038699N1
Completed
Phase 3
Evaluation of oral Selenium Sulfide effect on treatment of Refractory Obsessive Compulsive Disorder in a Randomized Double Blind Placebo-Controlled Clinical Trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ahvaz University of Medical Sciences
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 18 to 62 years
- •Minimum score of Yale brown questionnaire should be 21
- •Obtaining written informed consent before entering into the study
- •use fluoxetine 20 mg once a day
Exclusion Criteria
- •Internal diseases (diabetic patients , hypertension \& ...)
- •Psychotic patients and mood disorders and neurology diseases
- •Thinking about suicide
- •Addiction to alcohol and narcotics
- •IQ below 80
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Efficacy of oral selenium in treatment of sepsis in preterm neonatesHealth Condition 1: P369- Bacterial sepsis of newborn, unspecifiedCTRI/2024/07/070140Dr. DUMNE SWANEEK JAYANT
Completed
Not Applicable
Effects of oral administration of selenium on serum ferritin level and serum iron concentration in patients with Beta Thalassemia majorBetaThalassemia major.???????? ??? ????????? ?????? ?? ??? ???? ? ???????? ??? ?????????IRCT2017021226998N3Hematology and Oncology research center, Tabriz University of Medical Sciences34
Completed
Phase 2
Evaluation of the effect of oral selenium administration on tremor reduction of ParkinsoniansTremor.Parkinson diseaseIRCT201101155612N1Yazd University of Medical Sciences26
Completed
Phase 3
Selenium supplementation in the treatment of hemodialysis patientsIRCT20170513033941N62Islamic Azad University40
Completed
Phase 2
The effect of selenium in the treatment of acute traumatic brain injuryIRCT2015090223865N1Vice Chancellor for research of Iran University of Medical Sciences110